PRECIGEN, INC.

GERMANTOWN, MD How do I update this listing?

Precigen is based out of Germantown. Intrexon Corp. is a biotechnology company focused on collaborating with companies in Health, Food, Energy, and Environment to create biologically based products that improve quality of life and the health of the planet. At present rates of global industrialization and population growth, food and energy supplies and environmental and healthcare resources are becoming scarcer. Intrexon������s leading Better DNA approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment.Whalewisdom has at least 198 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-12-17. The notice included securities offered of Equity

Create Alert

Contact Info

precigen, inc.
20374 SENECA MEADOWS PARKWAY
GERMANTOWN MD    20876

Business Phone: 301-556-9900
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-12-17 D PHARMACEUTICALS Equity 13,000,000 13,000,000 0
2020-02-11 D BIOTECHNOLOGY Equity 35,000,000 35,000,000 0
2016-03-09 D BIOTECHNOLOGY Equity 4,250,000 4,250,000 0
2015-09-21 D BIOTECHNOLOGY Equity 21,585,401 21,585,401 0
2015-03-11 D BIOTECHNOLOGY Equity 450,015 450,015 0
2015-03-09 D BIOTECHNOLOGY Equity 10,196,546 10,196,546 0
2015-01-28 D BIOTECHNOLOGY Equity 57,500,000 57,500,000 0
2014-08-22 D BIOTECHNOLOGY Equity 28,634,166 28,634,166 0
2014-04-10 D BIOTECHNOLOGY Equity 24,999,943 24,999,943 0
2013-05-15 D/A BIOTECHNOLOGY Equity 150,000,000 150,000,000 0
2013-03-18 D BIOTECHNOLOGY Equity 150,000,000 64,409,342 85,590,658
2012-11-15 D BIOTECHNOLOGY Equity 25,000,002 25,000,002 0
2012-04-26 D/A BIOTECHNOLOGY Equity 75,000,006 75,000,006 0
2012-01-24 D/A BIOTECHNOLOGY Equity 50,000,003 50,000,003 0
2012-01-09 D BIOTECHNOLOGY Equity 50,000,000 17,000,000 33,000,000
2011-11-14 D BIOTECHNOLOGY Equity 1,092,344 1,092,344 0
2011-09-14 D BIOTECHNOLOGY Equity 17,000,004 17,000,004 0
2011-06-08 D BIOTECHNOLOGY Equity 91,825,055 91,825,055 0
2011-05-11 D BIOTECHNOLOGY Equity 550,001 550,001 0
2011-04-22 D/A BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 66,936,470 66,936,470 0
2011-02-18 D/A BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 55,953,968 55,953,968 0
2011-02-09 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 1,346,625 1,013,625 333,000
2010-11-12 D/A BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 37,506,714 37,506,714 0
2010-03-05 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 17,403,901 17,403,901 0
2010-01-05 D BIOTECHNOLOGY Equity 25,000,000 25,000,000 0
2009-06-29 D BIOTECHNOLOGY Equity 9,999,999 9,999,999 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BURTON SOBEL subscription required
    DIRECTOR
CESAR L. ALVAREZ subscription required
    DIRECTOR
COREY HUCK subscription required
    EXECUTIVE OFFICER
DARRYL WEBSTER subscription required
    EXECUTIVE OFFICER
DAVID J. ZACCARDI subscription required
    DIRECTOR
DEAN J. MITCHELL subscription required
    DIRECTOR
DONALD LEHR subscription required
    EXECUTIVE OFFICER
ENA CHAN CRATSENBURG subscription required
    EXECUTIVE OFFICER
FRED HASSAN subscription required
    DIRECTOR
GERARDO ZAPATA subscription required
    EXECUTIVE OFFICER
GLENN NEDWIN subscription required
    EXECUTIVE OFFICER
GRACE COLON subscription required
    EXECUTIVE OFFICER
GREGORY I. FROST subscription required
    EXECUTIVE OFFICER
HELEN SABZEVARI, PH.D. subscription required
    EXECUTIVE OFFICER
JACK A. BOBO subscription required
    EXECUTIVE OFFICER
JAMES S. TURLEY subscription required
    DIRECTOR
JAYSON RIEGER subscription required
    EXECUTIVE OFFICER
JEFFREY KINDLER subscription required
    DIRECTOR
JEFFREY T. PEREZ subscription required
    EXECUTIVE OFFICER
JOEL D. LIFFMAN subscription required
    EXECUTIVE OFFICER
JOEL D. LIFFMANN subscription required
    EXECUTIVE OFFICER
JOSEPH L. VAILLANCOURT subscription required
    EXECUTIVE OFFICER
KELLY HUANG subscription required
    EXECUTIVE OFFICER
KRISH S. KRISHNAN subscription required
    EXECUTIVE OFFICER
LARRY HORNER subscription required
    DIRECTOR
MARCELO QUIROGA subscription required
    EXECUTIVE OFFICER
MATT CRISP subscription required
    EXECUTIVE OFFICER
MATTHEW B. CRISP subscription required
    EXECUTIVE OFFICER
NICK MACRIS subscription required
    EXECUTIVE OFFICER
NIR NIMRODI subscription required
    EXECUTIVE OFFICER
OLIVIER R. JARRY subscription required
    EXECUTIVE OFFICER
RANDAL J. KIRK subscription required
    EXECUTIVE OFFICER DIRECTOR
RICK STERLING subscription required
    EXECUTIVE OFFICER
ROBERT P. BEECH subscription required
    EXECUTIVE OFFICER
ROBERT SHAPIRO subscription required
    DIRECTOR
ROBERT F. WALSH, III subscription required
    EXECUTIVE OFFICER
RONALD B. HERBERMAN subscription required
    EXECUTIVE OFFICER
SAIID ZARRABIAN subscription required
    EXECUTIVE OFFICER
SAMUEL BRODER subscription required
    EXECUTIVE OFFICER
STEVEN FRANK subscription required
    DIRECTOR
SUMA M. KRISHNAN subscription required
    EXECUTIVE OFFICER
SUNIL CHADA subscription required
    EXECUTIVE OFFICER
THOMAS KASSER subscription required
    EXECUTIVE OFFICER
THOMAS REED subscription required
    EXECUTIVE OFFICER DIRECTOR
THOMAS REED, PH.D. subscription required
    EXECUTIVE OFFICER
TIMOTHY KASBE subscription required
    EXECUTIVE OFFICER
TOM GORALSKI subscription required
    EXECUTIVE OFFICER
VINITA D. GUPTA subscription required
    DIRECTOR

Elevate your investments